2011
Treatment outcomes of a stage 1 cognitive–behavioral trial to reduce alcohol use among human immunodeficiency virus‐infected out‐patients in western Kenya
Papas RK, Sidle JE, Gakinya BN, Baliddawa JB, Martino S, Mwaniki MM, Songole R, Omolo OE, Kamanda AM, Ayuku DO, Ojwang C, Owino‐Ong'or W, Harrington M, Bryant KJ, Carroll KM, Justice AC, Hogan JW, Maisto SA. Treatment outcomes of a stage 1 cognitive–behavioral trial to reduce alcohol use among human immunodeficiency virus‐infected out‐patients in western Kenya. Addiction 2011, 106: 2156-2166. PMID: 21631622, PMCID: PMC3208780, DOI: 10.1111/j.1360-0443.2011.03518.x.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusAlcohol useDrinking daysLarge human immunodeficiency virusCognitive behavioral therapy interventionAlcohol intervention studyAlcohol use disorderGroup Cognitive Behavioral Therapy InterventionEffect sizeTreatment effect sizeCognitive behavioral therapyDual epidemicsRandomized participantsPatient clinicImmunodeficiency virusPreliminary efficacyHuman immunodeficiencyClinical trialsTreatment outcomesAlcohol abstinenceAssessment-only controlBinge drinkingUse disordersTherapy interventionFeasible intervention
2010
Refill Adherence to Oral Hypoglycemic Agents and Glycemic Control in Veterans
Kim N, Agostini JV, Justice AC. Refill Adherence to Oral Hypoglycemic Agents and Glycemic Control in Veterans. Annals Of Pharmacotherapy 2010, 44: 800-808. PMID: 20388863, PMCID: PMC3117591, DOI: 10.1345/aph.1m570.Peer-Reviewed Original ResearchConceptsOral hypoglycemic agentsGlycemic controlGoal A1CHypoglycemic agentsBaseline dateInadequate diabetes controlPercent of patientsPoor glycemic controlMain outcome measuresBaseline A1CContinuous refillNonpersistent patientsComorbid hypertensionDiabetes medicationsMedian ageBetter persistenceMedication nonadherenceDiabetes controlDays' supplyOutcome measuresClinical careEligible veteransPatientsA1CMedications
2007
Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies
Braithwaite RS, Kozal MJ, Chang CC, Roberts MS, Fultz SL, Goetz MB, Gibert C, Rodriguez-Barradas M, Mole L, Justice AC. Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies. AIDS 2007, 21: 1579-1589. PMID: 17630553, PMCID: PMC3460378, DOI: 10.1097/qad.0b013e3281532b31.Peer-Reviewed Original ResearchMeSH KeywordsAdultAlkynesAnti-HIV AgentsAntiretroviral Therapy, Highly ActiveBenzoxazinesCD4 Lymphocyte CountCohort StudiesCyclopropanesDrug Administration ScheduleFemaleHIV InfectionsHIV-1HumansMaleMiddle AgedPatient ComplianceReverse Transcriptase InhibitorsRNA, ViralTreatment OutcomeVeteransViral LoadConceptsPrevious antiretroviral exposureSingle PI regimensCombination ARTImmunological outcomesAntiretroviral exposureHIV RNAPI regimensProtease inhibitorsCombination antiretroviral therapy regimenHIV-RNA viral suppressionTreatment assignmentVeterans Affairs Healthcare SystemEfavirenz-based regimenGreater adherence levelsLog HIV RNAAntiretroviral therapy regimenBaseline clinical characteristicsCD4 cell countCombination antiretroviral therapyPharmacy refill recordsOutcome one yearAntiretroviral prescriptionsAntiretroviral regimensEfavirenz regimensNevirapine regimensEstimating the impact of alcohol consumption on survival for HIV+ individuals
Braithwaite RS, Conigliaro J, Roberts MS, Shechter S, Schaefer A, McGinnis K, Rodriguez MC, Rabeneck L, Bryant K, Justice AC. Estimating the impact of alcohol consumption on survival for HIV+ individuals. AIDS Care 2007, 19: 459-466. PMID: 17453583, PMCID: PMC3460376, DOI: 10.1080/09540120601095734.Peer-Reviewed Original ResearchConceptsAlcohol consumptionFrequency of consumptionDaily consumptionModifiable risk factorsLarge observational cohortHazardous alcohol consumptionDose-response relationshipImpact of alcoholHIV diseaseObservational cohortOverall survivalAntiretroviral adherencePoor outcomeRisk factorsPoor survivalClinical dataHazardous drinkersNonhazardous drinkersAdherence resultsAlcohol's impactSurvivalWeeksDrinkersAdherenceYears
2006
Explaining variability in the relationship between antiretroviral adherence and HIV mutation accumulation
Braithwaite RS, Shechter S, Roberts MS, Schaefer A, Bangsberg DR, Harrigan PR, Justice AC. Explaining variability in the relationship between antiretroviral adherence and HIV mutation accumulation. Journal Of Antimicrobial Chemotherapy 2006, 58: 1036-1043. PMID: 17023498, DOI: 10.1093/jac/dkl386.Peer-Reviewed Original ResearchHepatitis C coinfection is independently associated with decreased adherence to antiretroviral therapy in a population-based HIV cohort
Braitstein P, Justice A, Bangsberg DR, Yip B, Alfonso V, Schechter MT, Hogg RS, Montaner J. Hepatitis C coinfection is independently associated with decreased adherence to antiretroviral therapy in a population-based HIV cohort. AIDS 2006, 20: 323-331. PMID: 16439865, DOI: 10.1097/01.aids.0000198091.70325.f4.Peer-Reviewed Original ResearchConceptsInjection drug useAntiretroviral treatmentAntiretroviral therapyLiver injuryHigher plasma albumin levelCombination antiretroviral treatmentHepatitis C serostatusHepatitis C coinfectionPlasma albumin levelsMultivariate logistic regressionDrug treatment programsHIV/AIDSHCV seropositivityC coinfectionHCV antibodiesHIV cohortHCV serologyAlbumin levelsLow albuminPrimary outcomePrescription refillsPoor adherenceMale genderHIV therapyEligible individuals
2005
How Does Depression Influence Diabetes Medication Adherence in Older Patients?
Kilbourne AM, Reynolds CF, Good CB, Sereika SM, Justice AC, Fine MJ. How Does Depression Influence Diabetes Medication Adherence in Older Patients? American Journal Of Geriatric Psychiatry 2005, 13: 202-210. PMID: 15728751, DOI: 10.1097/00019442-200503000-00005.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAged, 80 and overDepressionDiabetes Mellitus, Type 2Epidemiologic MethodsHumansHypoglycemic AgentsMiddle AgedPatient ComplianceConceptsOverall medication adherenceMedication adherenceElectronic monitoring capsOlder patientsPharmacy dataBaseline surveyInadequate medication adherenceOral hypoglycemic medicationsPharmacy refill dataType 2 diabetesLower median percentagesPercentage of daysPercent of daysHypoglycemic medicationsAdequate medicationMedication useRefill dataPatients' baselineAdequate adherenceMedication coverageDepressed patientsDays' supplyPatient reportsPatientsMedian percentageAlgorithm for assessing patients' adherence to oral hypoglycemic medication.
Kilbourne AM, Good CB, Sereika SM, Justice AC, Fine MJ. Algorithm for assessing patients' adherence to oral hypoglycemic medication. American Journal Of Health-System Pharmacy 2005, 62: 198-204. PMID: 15700895, DOI: 10.1093/ajhp/62.2.198.Peer-Reviewed Original Research
2003
Understanding racial disparities in HIV using data from the veterans aging cohort 3-site study and VA administrative data.
McGinnis KA, Fine MJ, Sharma RK, Skanderson M, Wagner JH, Rodriguez-Barradas MC, Rabeneck L, Justice AC. Understanding racial disparities in HIV using data from the veterans aging cohort 3-site study and VA administrative data. American Journal Of Public Health 2003, 93: 1728-33. PMID: 14534229, PMCID: PMC1448041, DOI: 10.2105/ajph.93.10.1728.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAntiretroviral Therapy, Highly ActiveBlack or African AmericanCohort StudiesDisease ManagementFemaleHispanic or LatinoHIV SeropositivityHumansMaleMiddle AgedPatient Acceptance of Health CarePatient ComplianceProportional Hazards ModelsSocioeconomic FactorsSurvival AnalysisUnited StatesUnited States Department of Veterans AffairsVeteransWhite PeopleConceptsWhite veteransClinical managementMinority veteransHealth statusVeterans Aging CohortSeverity of illnessVA administrative dataRace-associated differencesHigh mortality ratePatients' health statusNational administrative dataAdministrative dataPossible etiologiesUS veteransPoor survivalMortality rateAging CohortHIVPoor healthRacial disparitiesVeteransSignificant differencesSurvivalCohortAdherence
2001
Patient- and provider-reported adherence toward a clinically useful approach to measuring antiretroviral adherence
Wagner JH, Justice AC, Chesney M, Sinclair G, Weissman S, Rodriguez-Barradas M, Team F. Patient- and provider-reported adherence toward a clinically useful approach to measuring antiretroviral adherence. Journal Of Clinical Epidemiology 2001, 54: s91-s98. PMID: 11750214, DOI: 10.1016/s0895-4356(01)00450-4.Peer-Reviewed Original ResearchConceptsAlcohol Use Disorders Identification TestViral loadProvider assessmentCurrent drug useDepressive symptomsCurrent alcohol usePatient reportsDrug useAlcohol useIndependent associationVeterans Affairs Health Care SystemPatient-reported adherenceCurrent viral loadPharmacy refill dataAntiretroviral medication adherenceEpidemiological Studies DepressionIllicit drug useDisorders Identification TestElectronic laboratory dataHealth care systemRefill dataMedication adherencePatient adherenceAntiretroviral adherenceMultivariate regression model